Montefiore Einstein Cancer Center | Strategic Alliance Partners

Latest from Montefiore Einstein Cancer Center

Dr. Halmos on Trastuzumab Deruxtecan in NSCLC

November 14, 2022

Balazs Halmos, MD, discusses the importance of testing for HER2 mutations and exon 20 insertions, which are emerging new targets in non–small cell lung cancer, and how fam-trastuzumab deruxtecan-nxki meets needs for patients with HER2-mutant disease.

Montefiore Einstein Cancer Center Researchers Receive Price Family Foundation Health Equity Research Awards

August 11, 2022

The National Cancer Institute-designated Montefiore Einstein Cancer Center has partnered with the Price Family Foundation to fund 8 research teams developing novel cancer therapies and improving cancer outcomes for historically marginalized communities in the Bronx.

New Cancer Study Results Confirm Lasting Effects on 9/11 First Responders

August 05, 2022

Research investigating the physical and mental health consequences of being at the World Trade Center site during and after the terrorist attacks has been instrumental in obtaining health care coverage for thousands of individuals.

Montefiore Einstein Cancer Center Finds CAR T-Cell Therapy Effective in Black and Hispanic Patients

June 02, 2022

Investigators at the Montefiore Einstein Cancer Center report that Black and Hispanic patients had outcomes and side effects following CAR-T treatment that were comparable to their white and Asian counterparts, according to findings from a study published in Bone Marrow Transplantation.

Cancer Dormancy and Tumor Microenvironment Institute to Take Research Efforts to Greater Heights

October 29, 2021

The Cancer Dormancy and Tumor Microenvironment Institute, which has recently been launched at Albert Einstein Cancer Center, will focus on taking the tumor microenvironment research being done at the center to the next level and to develop novel technologies that can better identify dormant cancer as well as prevent and control recurrent disease.

Focus on Health Equity in Cancer Care Leads to National Recognition

August 26, 2021

Montefiore Einstein Cancer Center has once again earned national recognition for its quality of care studies leading to enhanced patient care, its strong cancer screening and early detection initiatives, and its exceptional support services.

Lauren Hackett, MPA, to Lead Operations at NCI-Designated Albert Einstein Cancer Center

June 25, 2021

Albert Einstein Cancer Center, Albert Einstein College of Medicine, and Montefiore Health System announced that Lauren Hackett, MPA, has been appointed the deputy director of administration of AECC and associate vice president of cancer medicine at Montefiore Medicine.

Halmos Highlights Effort Exploring COVID-19 Vaccines in Patients With Cancer

June 24, 2021

Dr. Halmos discusses the data from a study examining seroconversion rates following COVID-19 vaccination among patients with cancer and underscores the need for novel vaccination or passive immunization strategies for immunosuppressed cohorts.

Prominent Scientist Julio Aguirre-Ghiso, Ph.D., To Lead New Cancer Dormancy and Tumor Microenvironment Institute at Albert Einstein Cancer Center

June 16, 2021

Leading cancer biologist Julio Aguirre-Ghiso, PhD, has been named founding director of the Cancer Dormancy and Tumor Microenvironment Institute, director of the Gruss-Lipper Biophotonics Center, and co-leader of the AECC Tumor Microenvironment and Metastasis Program.